hr ve /her2neu-ve advanced breast cancer: how do i manage and why? | shaheena dawood
Published 2 years ago • 168 plays • Length 25:19Download video MP4
Download video MP3
Similar videos
-
1:01:35
her2 treatment
-
13:08
her2 positive breast cancer: everything you must know
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
9:36
neoadjuvant therapy for hr breast cancer
-
1:11
dr. hurvitz on importance of biosimilars in her2 breast cancer
-
4:09
her2 breast cancer: neratinib patient selection
-
27:18
escalated and de-escalated neoadjuvantin hr-/her2 early breast cancer dr. shadi alkhayyat
-
0:52
defining her2-low breast cancer as a clinical subtype
-
4:44
an overview of recent metastatic her2 breast cancer trials
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
55:30
breaking down barriers to treatment adherence and persistence in hr /her2- early breast cancer
-
8:03
refining neoadjuvant chemotherapy for her2 breast cancer
-
2:06
exploring novel therapeutic approaches in hr / her2- mbc
-
3:46
outcomes from adapt-hr-/her2 evaluating dual her2 blockade
-
2:19
her2 heterogeneity and neoadjuvant therapy in breast cancer
-
1:31
new treatment for her2 low metastatic breast cancer (hb 422)
-
2:15
dr. hurvitz on neoadjuvant therapy for her2 breast cancer
-
1:39:53
personalized update on breast cancer